Enanta Pharma Revenue, Profits - ENTA Annual Income Statement

Add to My Stocks
$90.93 $0.81 (0.88%) ENTA stock closing price Sep 18, 2018 (Closing)

Looking at financial statements, along with the Enanta Pharma stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase to $102.81M for 2017 impacts the ENTA stock. Investors typically check year over year or quarter over quarter revenue growth. Along with Enanta Pharma assets and Enanta Pharma free cash flow, Enanta Pharma profits as shown in profit and loss statement give key insights about the business. The net profit for 2017 is $17.71M and the 2017 revenue is $102.81M.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Oct - Sep20172016201520142013201220112010
Enanta Pharma Revenues or Net Sales
102.81M88.26M160.88M47.74M32.05M41.7M41.88M22.76M
Cost Of Goods Sold (COGS)--------
Enanta Pharma Gross Profit
102.81M88.26M160.88M47.74M32.05M41.7M41.88M22.76M
Research & Development Expense57.45M40.46M23.18M18.74M16.84M15.11M11.54M9.71M
Selling General & Admin Expense20.74M16.96M13.54M10.01M6.18M5.3M5.03M6.1M
Income Before Depreciation Depletion Amortization24.61M30.84M124.14M18.98M9.02M21.28M25.29M6.94M
Depreciation Depletion Amortization--------
Non Operating Income2.37M1.76M1.31M---1.17M-
Interest Expense------3.16M-
Enanta Pharma Pretax Income
26.94M32.56M125.45M19.26M9.62M21.39M23.31M7.74M
Provision for Income Taxes9.23M10.89M46.46M-15.17M----
MinorityInterest--------
Investment Gains Losses--------
Other Income--------
Income Before Extraordinaries & Disc Operations17.71M21.66M78.99M34.43M9.62M21.39M23.31M7.59M
Extraordinary Items & Discontinued Operations--------
Enanta Pharma Profit/ Loss (Net Income)
17.71M21.66M78.99M34.43M9.62M21.39M23.31M7.9M
Average Shares used to compute Diluted EPS19.41M19.22M19.3M19.19M9.79M2.48M--
Average Shares used to compute Basic EPS19.07M18.93M18.67M18.36M9.79M1.09M--
Income Before Nonrecurring Items17.71M21.67M78.99M34.44M9.63M21.4M--
Income from Nonrecurring Items--------
Enanta Pharma Earnings Per Share Basic Net
0.931.144.231.88-0.671.26--
Enanta Pharma Earnings Per Share Diluted Net
0.911.134.091.80-0.671.13--
EPS Diluted Before Nonrecurring Items0.911.134.091.80-0.671.13--
Preferred Dividends Acc Pd--------
Dividends Common--------
Dividend Per Share Common0.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Enanta Pharma stock analysis involves checking at least a few of the important things like:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $102.81M for this year of 2017. Our Enanta Pharma revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $17.71M for ENTA stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the ENTA income statement, one can check the Enanta Pharma historical stock prices to check how the price has moved with time.

Enanta Pharma Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
22.56
PS Ratio (price sales ratio)
8.15
Operating Margin
39.5
Net Profit Margin
35.4
Dividend Yield
0%